Market revenue in 2022 | USD 563.8 million |
Market revenue in 2030 | USD 2,114.0 million |
Growth rate | 18% (CAGR from 2022 to 2030) |
Largest segment | Consumables |
Fastest growing segment | Consumables |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Instruments |
Key market players worldwide | Thermo Fisher Scientific Inc, Qiagen NV, Bio-Rad Laboratories Inc, Illumina Inc, Merck KGaA, Becton Dickinson & Co, Standard BioTools Inc, 10x Genomics Inc Ordinary Shares - Class A, BGI Group, Novogene |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to single cell analysis market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 54.86% in 2022. Horizon Databook has segmented the Asia Pacific single cell analysis market based on consumables, instruments covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific is the fastest-growing region, owing to the rapidly developing economy, rising geriatric population, and growing investments in the biotechnology sector. Key factors driving Asia Pacific's single-cell analysis market include increasing demand for biotech tools in R&D activities, improving adoption of laboratory automation, and growing government attention on biotech & healthcare sectors.
According to the Asia Pacific Observatory on Health Systems and Policies in September 2021, the rapidly aging population and the rising burden of chronic disorders are some of the factors boosting the need for and adoption of integrated care models in the region.
As per Healthcare IT News in September 2023, emerging healthcare trends in the Asia Pacific region include home hospitalization, technology-enabled preventive care, and personalized care driven by genomic data.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific single cell analysis market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific single cell analysis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account